Page 5 - Automated Cell News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Hemostemix Announces Its Intellectual Property is Back Home

Hemostemix Announces Its Intellectual Property is Back Home
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

South africaUnited statesJed woodEastern capeSouth africanThomas smeenkReginald cooperBrandi woodBlake woodAlan jacobsKyle makofkaWorld economic forum technology pioneer awardHemostemix incRegulation service providerHealth services incAlberta newsfile corp

Hemostemix Announces Closing of $2,750,000

Hemostemix Announces Closing of $2,750,000
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Red deerThomas smeenkPeter laceyVenture exchange theHealth scienceRegulation service providerCommon shares of the companyCompany commonWorld economic forum technology pioneer awardAccudata solutions incHemostemix incAlberta newsfile corpVenture exchangeBoard of directors the companyDebenture unitCommon shares

Hemostemix Inc Announces Intellectual Property Due Diligence and Data Audit Completed

Calgary, Alberta (Newsfile Corp. - April 12, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VFO) ("Hemostemix" or the "Company") is pleased to announce that, further to its March 23, 2022

Thomas smeenkWorld economic forum technology pioneer awardAccudata solutions incHemostemix incRegulation service providerAlberta newsfile corpVenture exchangeHealth sciencesAspire health sciencesAccudata solutionsSettlement agreementIschemic cardiomyopathyDilated cardiomyopathyStem cell treatmentRegulating stem cellsVitro techniques

Hemostemix Inc : Hemostemix Announces Settlement Agreement

Calgary, Alberta (Newsfile Corp. - March 23, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VFO) ("Hemostemix" or the "Company") is pleased to announce that it has entered into a settlement

United statesThomas smeenkWorld economic forum technology pioneer awardHemostemix incHealth scienceRegulation service providerAlberta newsfile corpVenture exchangeAspire health scienceDelaware federal actionFlorida state actionFlorida federal actionSettlement agreementData auditIschemic cardiomyopathyDilated cardiomyopathy

Hemostemix Inc : Hemostemix Announces $2,750,000 Convertible Debenture

Calgary, Alberta (Newsfile Corp. - March 2, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VFO) ("Hemostemix" or the "Company") is pleased to announce that it has signed a binding term sheet

Thomas smeenkVenture exchange theCommon shares of the company debentureRegulation service providerCommon shares of the companyWorld economic forum technology pioneer awardHemostemix incAlberta newsfile corpVenture exchangeBoard of directors the companyEach debenture unitCommon sharesCommon shareMarket priceConversion priceEach debenture warrant